Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Evolution of metal ions in biological systems wikipedia , lookup
Fatty acid metabolism wikipedia , lookup
Mitochondrial replacement therapy wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Glyceroneogenesis wikipedia , lookup
Metabolomics wikipedia , lookup
Wilson's disease wikipedia , lookup
Basal metabolic rate wikipedia , lookup
Metabolic diseases of the liver • • • • • Central role in metabolism Causes and mechanisms of dysfunction Clinical patterns of metabolic disease Clinical approach to problem-solving Specific disorders Liver’s central role in metabolism Pathways involve CHO, protein, lipid, trace element and vitamin metabolism • Synthesis e.g. serum proteins • Detoxification/degradation e.g. ammonia • Regulation e..g. blood glucose Metabolic function of the liver Reactions disturbed by • • • • • Congenital deficiency of enzymes Nutritional deficiency/excess of substrate Toxic/chemical damage to organelles Hypoxic/ischaemic insult Secondary to metabolic effects of disease Metabolic disorders • • • • • • • of amino acid metabolism of bile acid synthesis and metabolism of carbohydrate metabolism of bile flow and excretion of mitochondrial function of peroxisomal function of copper metabolism Metabolic dysfunction : inherited disease • Essential product deficit e.g. G-6-P deficiency (Glycogen storage I) • Precursor accumulation e.g. OTC deficiency (Hyperammonaemia) • Alternative pathway activation e.g. Aminoacidopathy • Combinations of above Mitochondrial damage • Inhibition of beta oxygenation of fatty acids leads to microvesicular steatosis • Interference with oxidative phosphorylation leads to insufficient ATP generation • Impairment of the respiratory chain leads to excess ROS with lipid peroxidation • Increase in permeability transition leads to cell death (apoptosis) Mitochondrial dysfunction • Inborn enzyme deficiencies involving: fatty acid oxygenation organic acids lactate metabolism oxidative phosphorylation urea cycle Episodic decompensation precipitated by intercurrent stress Toxic damage to liver • Mitochondrial damage Drugs (antivirals, salicylate, valproate, tetracycline) Toxins (hypoglycin, atractyloside) • Endothelial damage to hepatic veins Drugs (cytotoxic drugs) Toxins (Senecio, aflatoxin, pyrrolizidine) • Glutathione depletion and cell death Drugs (paracetamol) Hypoxic ischaemia Mechanisms of centrilobular necrosis • • • • Sepsis Shock induced ischaemia Congestive heart failure Toxicity from drugs and poisons made worse by Malnutrition Infection Fasting Exercise Pathologic manifestations of metabolic disease of the liver • No structural abnormalities evident but severe functional disturbance • Hepatocyte injury leading to apoptosis, necrosis, cirrhosis or tumours • Storage of lipid, glycogen or other products manifesting as hepatomegaly Clinical patterns of metabolic disease involving the liver • Newborn acute metabolic crisis mimics sepsis • Severe vomiting and failure to thrive • Recurrent episodes of vomiting and encephalopathy with acidosis • Progressive retardation or seizures with hepatomegaly • Hepatomegaly with/without jaundice and failure to thrive/grow normally Inherited metabolic disease presenting with acute onset liver failure “Reye-like” Typical age Neonatal to 3 years Past history Episodic vomiting since neonatal period, possible failure to thrive, possible family history Preceding history Abnormal stress such as infection, fasting, exercise Clinical features Progressive encephalopathy and anicteric multisystem failure and acidosis Inherited metabolic disease presenting with acute onset liver failure “Reye-like” Typical biochemical findings Hypoglycaemia. Ketosis often absent. Metabolic acidosis. Transaminases elevated. Hyperammonaemia. Prolonged prothrombin time. Decreased serum albumin. Leucocytosis. Raised acute phase reactants. Functional disturbance Mitochondrial dysfunction Pathology Microvesicular steatosis Treatment Supportive for liver failure : attend to hypoglycaemia, acidosis, bleeding tendency, hyperammonaemia.